Target was Hit on Gilead Sciences (GILD) for 4.9% Gain.

POST UPDATED: April 24, 2023

Target was Hit on Gilead Sciences Inc. (GILD) at $87 for a 4.9 % Gain. (Long Term Portfolio).

Become a Greenliner. Join Today

Candlestick. A Swing Traders Friend

A snapshot of the daily updates that help traders stay aligned with market direction.